| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.061 | 0.2 |